CC
GH icon

Chicago Capital’s Guardant Health GH Stock Holding History

Chicago Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-106,252
Closed -$5.72M – 233
2022
Q3 		$5.72M Buy
106,252
+7,778
+8% +$399K 0.33% 55
2022
Q2 		$3.97M Sell
98,474
-147,812
-60% -$7.32M 0.22% 63
2022
Q1 		$16.3M Buy
246,286
+1,682
+0.7% +$115K 0.7% 43
2021
Q4 		$24.5M Sell
244,604
-2,327
-0.9% -$241K 0.91% 37
2021
Q3 		$30.9M Sell
246,931
-2,887
-1% -$343K 1.17% 37
2021
Q2 		$31M Buy
249,818
+136
+0.1% +$18.3K 1.21% 37
2021
Q1 		$38.1M Sell
249,682
-1,951
-0.8% -$295K 1.61% 31
2020
Q4 		$32.4M Sell
251,633
-443
-0.2% -$51K 1.45% 31
2020
Q3 		$28.2M Buy
252,076
+1,298
+0.5% +$119K 1.45% 30
2020
Q2 		$20.3M Buy
250,778
+48,443
+24% +$3.9M 1.18% 33
2020
Q1 		$14.1M Buy
202,335
+120,965
+149% +$9.28M 1.14% 33
2019
Q4 		$6.36M Buy
+81,370
New +$5.86M 0.39% 53

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Chicago Capital's GH Position: Q4 2022 in Review

Chicago Capital sold out of Guardant Health (GH) in Q4 2022, closing a stake of 106,252 shares — an estimated $5.72M sold.

Chicago Capital first reported a position in GH in Q4 2019 and held it in 12 quarters. The position peaked at $38.1M in Q1 2021. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Chicago Capital reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Chicago Capital sold 106,252 Guardant Health shares in Q4 2022, an estimated $5.72M.
  • Chicago Capital first reported a position in Guardant Health in Q4 2019 and held it in 12 quarters.
  • Chicago Capital's Guardant Health position peaked at $38.1M in Q1 2021.
  • 290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Chicago Capital's 13F filing for Q4 2022, filed 20 Jan 2023.